RecruitingNCT05964504

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Improving Survival for Those With Metastatic Lobular Breast Cancer Through Development of the Multi-center PLUMB Registry-a Prospective Study of LobUlar Metastatic Breast Cancer


Sponsor

University of California, San Francisco

Enrollment

12 participants

Start Date

Dec 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study (the PLUMB Registry) is collecting real-world data on patients with metastatic lobular breast cancer — a type of breast cancer that spreads in a different pattern than most breast cancers and can be harder to detect and treat. The goal is to better understand how this cancer behaves and which treatments work best. **You may be eligible if...** - You have confirmed invasive lobular breast cancer (mixed lobular/ductal is also allowed) - Your cancer has spread to other parts of the body (stage IV / metastatic) - You are 18 or older - You are willing and able to give informed consent **You may NOT be eligible if...** - Your cancer is early-stage (stage I–III) and has not spread - Your tumor biopsy does not confirm lobular histology - You have another active cancer at the same time (prior treated cancers with no current evidence of disease are generally allowed) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBlood Specimen

Blood will be drawn via venipuncture


Locations(4)

University of California, San Diego

San Diego, California, United States

University of California, San Francisco

San Francisco, California, United States

Abramson Cancer Center

Philadelphia, Pennsylvania, United States

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05964504


Related Trials